LUND, Sweden, March 21, 2025 /PRNewswire/ — Hansa Biopharma AB, “Hansa” or the “Company” (NASDAQ Stockholm: HNSA), today published its Annual and Sustainability Reports for 2024. Peter Nicklin, Chair of the Board, Hansa Biopharma, said: “Hansa delivered several important milestones in…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.